7th Neuropsychiatric Drug Development Summit
Evvnt Promotion / evvnt
24.09.2024 - 26.09.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Temas de la conferencia
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
Organizador profesional (PCO)
Hanson Wade Group
Hanson Wade Group
Observaciones
URL:
Brochure: https://go.evvnt.com/2433814-3?pid=4832
Speakers: Aaron Koenig, Chief Medical Officer, Delix Therapeutics, Ariana Mullin, Director, Regulatory Affairs, Bristol Myers Squibb, and more
URL:
Brochure: https://go.evvnt.com/2433814-3?pid=4832
Speakers: Aaron Koenig, Chief Medical Officer, Delix Therapeutics, Ariana Mullin, Director, Regulatory Affairs, Bristol Myers Squibb, and more
Información e inscripción:
https://go.evvnt.com/2433814-2?pid=4832
Ms. Erin Thomas
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Drug Developer Pricing - Conference + Workshop Day: USD 3597.00, Drug Developer Pricing - Conference Only: USD 2599.00, Solution Provider Pricing - Conference + Workshop Day: USD 5197.00, Solution Provider Pricing - Conference Only: USD 3699.00
Drug Developer Pricing - Conference + Workshop Day: USD 3597.00, Drug Developer Pricing - Conference Only: USD 2599.00, Solution Provider Pricing - Conference + Workshop Day: USD 5197.00, Solution Provider Pricing - Conference Only: USD 3699.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
